State pauses Johnson & Johnson COVID-19 vaccine distribution

Department of Health rescheduling events, communicating with J&J recipients 

Santa Fe--The New Mexico Department of Health on Tuesday announced that Johnson & Johnson COVID vaccine distribution will be paused following federal Center for Disease Control and Food and Drug Administration recommendations. These announcements follow reports of six “rare and severe” blood clots - out of 6.8 million doses given - among women between the ages of 18 and 48 in the United States. Symptoms occurred 6 to 13 days after vaccination.   

“New Mexico - like the federal government - is acting out of an abundance of caution,” said DOH Secretary Dr. Tracie Collins. “As we learn more, we will share that information.”  

Scheduled J&J events and vaccinations will be paused or shifted to Pfizer and Moderna. 

People who have received the J&J vaccine who develop severe headache, blurred vision, seizure, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider. Health care providers should report adverse events to the Vaccine Adverse Events Reporting System at https://vaers.hhs.gov/reportevent.html. Please note: these adverse events are extremely rare - less than one per million.

Media Contact

We would be happy to provide additional information about this press release. Simply contact Matt Bieber at 505-470-2290 (Office) with your questions.

Versión en Español

En un esfuerzo para hacer que nuestros comunicados de prensa sean más accesibles, también tenemos disponibles una versión en español. Por favor presione el enlace de abajo para acceder a la traducción.

El Estado pausa la distribución de la vacuna para COVID-19 Johnson & Johnson